Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Entrectinib, sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (TRK) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Entrectinib.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Entrectinib shows recurring relationship patterns in the source. For example, Entrectinib → ALK-positive, Asia/Pacific, Drug Administration, EU, EudraCT, Europe, FDA, FDA-approved, Food, Health, In, In June, It, Japanese Ministry, Labour, MHLW, NCT02097810, NCT02568267, NCT02650401, NSCLC Another extracted example is Entrectinib → AACR American Association, April, Cancer Research Conference, Examples, II, Interim, NSCLC, NTRK, NTRK/ROS1/ALK, STARTRK-2, The. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cancer ros1 kinase ntrk tyrosine solid cell drug tumors inhibitor alk approved treatment lung receptor side effects nsclc patients gene
TTTA extracted 90 structured relationships around Entrectinib. Examples in this analysis include Entrectinib → 3D model (JSmol) → Interactive image and Entrectinib → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Entrectinib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Entrectinib | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Entrectinib | ATC code | L01EX14 (WHO) | 1.00 | infobox |
| Entrectinib | CAS Number | 1108743-60-7 | 1.00 | infobox |
| Entrectinib | ChEBI | CHEBI:195558 | 1.00 | infobox |
| Entrectinib | ChEMBL | ChEMBL1983268 | 1.00 | infobox |
| Entrectinib | ChemSpider | 24808589 | 1.00 | infobox |
| Entrectinib | CompTox Dashboard (EPA) | DTXSID101026450 | 1.00 | infobox |
| Entrectinib | Drug class | Antineoplastic agent | 1.00 | infobox |
| Entrectinib | DrugBank | DB11986 | 1.00 | infobox |
| Entrectinib | Formula | C31H34F2N6O2 | 1.00 | infobox |
| Entrectinib | KEGG | D10926 | 1.00 | infobox |
| Entrectinib | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Entrectinib | Legal status | CA: ℞-only | 1.00 | infobox |
| Entrectinib | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Entrectinib | Legal status | US: ℞-only | 1.00 | infobox |
| Entrectinib | Legal status | EU: Rx-only | 1.00 | infobox |
| Entrectinib | License data | US DailyMed: Entrectinib | 1.00 | infobox |
| Entrectinib | MedlinePlus | a619049 | 1.00 | infobox |
| Entrectinib | Molar mass | 560.650 g·mol−1 | 1.00 | infobox |
| Entrectinib | Other names | RXDX-101, NMS-E628 | 1.00 | infobox |
| Entrectinib | Pregnancy category | AU: D | 1.00 | infobox |
| Entrectinib | PubChem CID | 25141092 | 1.00 | infobox |
| Entrectinib | PubChem SID | 347828307 | 1.00 | infobox |
| Entrectinib | Routes of administration | By mouth | 1.00 | infobox |
| Entrectinib | Trade names | Rozlytrek | 1.00 | infobox |
| Entrectinib | UNII | L5ORF0AN1I | 1.00 | infobox |
| Entrectinib | is a | selective tyrosine kinase inhibitor with specificity | 0.90 | text |
The concept neighborhoods around Entrectinib bring nearby vocabulary together. In this analysis, examples include Cancer, Solid and Ntrk. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Entrectinib, one of the stronger structural bridges in this analysis connects Entrectinib with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Entrectinib to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Entrectinib · EN edition · Analysis: TopicsToTalkAbout